A Phase I study to evaluate the Pharmacokinetics and Safety of Letrozole LEBE in Healthy Post-menopausal Women.
Phase 1
Recruiting
- Conditions
- Healthy Post-menopausal women.MedDRA version: 21.1Level: PTClassification code: 10051775Term: Postmenopause Class: 100000004869Therapeutic area: Diseases [C] - Neoplasms [C04]
- Registration Number
- CTIS2023-503948-13-00
- Lead Sponsor
- aboratorios Farmaceuticos Rovi S.A.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 90
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method